[1]
“Formulation development and evaluation of taste-masked Moxifloxacin dispersible tablets for the treatment of pediatric tuberculosis”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 2, pp. 169–175, Mar. 2023, doi: 10.25004/IJPSDR.2023.150208.